# A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

> **NCT02175303** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Karolinska Institutet** · enrollment: 25 (estimated)

## Conditions studied

- Acute Lung Injury
- Decidual Stromal Cells
- Stem Cell Transplantation
- Inflammation

## Interventions

- **BIOLOGICAL:** Decidual stromal cell therapy

## Key facts

- **NCT ID:** NCT02175303
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175303, "A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02175303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*